Baseline characteristics from TANGO: Phase 2 study to evaluate gosuranemab (BIIB092) in patients with early Alzheimer’s disease: Human: Improving clinical trial methodology von Ratti, Elena, Kong, Jessica, O'Gorman, John, Rajagovindan, Raj, Racine, Annie, Graham, Danielle, Schrempp, Daniela Ramirez, Viollet, Louis, Jones, Stephanie, Mirabile, Tracy, Walsh, Dominic M., von Rosenstiel, Philipp, Shulman, Melanie

Volltext

Baseline characteristics from TANGO: Phase 2 study to evaluate gosuranemab (BIIB092) in patients with early Alzheimer’s disease von Ratti, Elena, Kong, Jessica, O'Gorman, John, Rajagovindan, Raj, Racine, Annie, Graham, Danielle, Schrempp, Daniela Ramirez, Viollet, Louis, Jones, Stephanie, Mirabile, Tracy, Walsh, Dominic M., von Rosenstiel, Philipp, Shulman, Melanie

Volltext

Species-specific Inflammatory Responses as a Primary Component for the Development of Glomerular Lesions in Mice and Monkeys Following Chronic Administration of a Second-generation... von Frazier, Kendall S., Sobry, Cécile, Derr, Victoria, Adams, Mike J., Besten, Cathaline Den, Kimpe, Sjef De, Francis, Ian, Gales, Tracy L., Haworth, Richard, Maguire, Shaun R., Mirabile, Rosanna C., Mullins, David, Palate, Bernard, Doorten, Yolanda Ponstein-Simarro, Ridings, James E., Scicchitano, Marshall S., Silvano, Jérémy, Woodfine, Jennie

Volltext

Novel Vascular Lesions in Mice Given a Non-Peptide Vitronectin Receptor Antagonist von Rehm, Sabine, Thomas, Roberta A., Smith, Kim S., Mirabile, Rosanna C., Gales, Tracy L., Eustis, Scot L., Boyce, Rogely W.

Volltext